Other substances

CM02

A cinanserine derivate.

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Experimental

1
 Supporting references
0
 Contradictory references
0
 AI-suggested references
0
 Clinical trials

General information

CM02 cinanserin derivate was predicted to inhibit the SARS-CoV-2 3C-like protease based on in silico models (Stoddard et al., 2020).

Synonyms

Cinanserin derivate CM02

 

Supporting references

Link Tested on Impact factor Notes Publication date
Optimization Rules for SARS-CoV-2 Mpro Antivirals: Ensemble Docking and Exploration of the Coronavirus Protease Active Site
3CLpro Small molecule In silico 		in silico 3.82

A cinanserin derivate predicted to inhibit the SARS-CoV-2 3C-like protease.

 Aug/26/2020
Export (.csv)